乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Gastroenterology >

Hepatitis

News, opinions and meeting coverage in gastroenterology.

<乌鸦传媒>Hepatitis C Treatment Works Well for Young Kids

Nearly all children treated with sofosbuvir/ledipasvir achieved sustained response

<乌鸦传媒>Pregnant Women at Risk for HCV Benefit from Universal Screen

Test deemed more efficient, cost-effective diagnostic approach versus risk-based screening

<乌鸦传媒>Liver Meeting to Focus on Practice Matters Along with Science

Topics range from 'day in the life' of a hepatology consultant to novel NASH therapies

<乌鸦传媒>ACIP: Routinely Vaccinate Homeless Against HepA

Homelessness denotes increased risk for contracting disease

<乌鸦传媒>Outbreak-Related Hep A Infections on the Rise

2017 data showed dramatic increases

<乌鸦传媒>FDA Approves New Formulation of HepA Immune Globulin

Product also offers post-exposure prophylaxis against measles

<乌鸦传媒>Proposed: Screen Patients with Certain Infections for Opioid Addiction

Expert panel identifies endocarditis, skin abscess, others as flags for drug abuse

<乌鸦传媒>Shorter Wait Times May Favor HCV-Infected Kidney Transplants

Long-term dialysis while waiting for uninfected kidney a larger risk

<乌鸦传媒>Medicaid or No Insurance Tied to Higher Death Risk in HCV

All public plans lead to higher mortality rates, according to 10-year study

<乌鸦传媒>Hepatitis D: The 'Forgotten Virus' is Still Here

More attention to screening, treatment is needed, say experts

<乌鸦传媒>Survival Prognosis Still Poor for Alcoholic Hepatitis

Four decades of no improvement show urgent need for better treatments

<乌鸦传媒>It's Official! Curing Patients Is Bad for Business

Milton Packer describes the end result of profit-dominated drug development

<乌鸦传媒>Hepatitis C Treatments Reduce Transplants

Therapies also appear to reduce liver-related mortality

<乌鸦传媒>Europe Gets Updated HCV Tx Guidelines

EASL panel touts 'ease of use' of direct-acting antivirals

<乌鸦传媒>ACIP Backs Hep A Vax in Outbreaks

Unanimous vote to support use as post-exposure prophylaxis

<乌鸦传媒>ACIP Reinstates FluMist for 2018-2019 Flu Season

Committee persuaded by new efficacy analyses

<乌鸦传媒>Experts Raise Red Flag over Fatty Liver Disease

Paints gloomy picture for population health, economy

<乌鸦传媒>Vets with HCV Might Settle Cancer Controversy

VA experience seems to rule out possible cancer-causing effect of new drugs

<乌鸦传媒>Novel Tx for Hepatic Encephalopathy Works Fast

Lowers ammonia level more quickly than standard care, study finds

<乌鸦传媒>Liver Ca Transplant Rates Vary by Ethnicity

Blacks have lower rates despite same degree of illness, study finds

<乌鸦传媒>AASLD Liver Meeting Covers a Lot of Ground

New science could 'potentially change the field'

<乌鸦传媒>Hepatitis A Outbreak to Greet IDWeek

Homeless bear brunt of disease; delegates at low risk

<乌鸦传媒>Morning Break: Antibiotics Running Out; Teen Sex Interest Drops; Children Drive to OR

Health news and commentary from around the Web gathered by the 乌鸦传媒 staff

<乌鸦传媒>Does a New Hepatitis Vaccine Cause Heart Attacks?

In this Revolution and Revelation, Milton Packer asks how you would answer this question

<乌鸦传媒>AIDS Science Meeting Returns to Paris

Leaders vow to battle to preserve research into virus

<乌鸦传媒>Gilead's 3-Drug Combo Pill OK'd for 2nd-Line HCV Treatment

Indicated for all six HCV genotypes in patients needing retreatment

<乌鸦传媒>DDW 2017: Diversity Will Be Meeting's Strength

Four-society meeting has plenty to offer across and among specialties

<乌鸦传媒>ACIP: One-Dose HepB Vax OK for Some Infants Needing Revaccination

Two more doses needed if infant still non-responsive after testing, committee advises

<乌鸦传媒>Coffee, Genetics May Block Hepatitis in Heavy Drinkers

Gene variant also shows possible liver-protective effect

<乌鸦传媒>Hep C Virus Outbreak Tied to Unsafe Injection Practices

Calif. prolotherapy clinic shuttered after patients developed HCV infections

<乌鸦传媒>Investigative Combo Pill Effective Against HCV Infection

Treating refractory HCV without ribavirin onboard.

<乌鸦传媒>Simple, Short HCV Regimen Has High Cure Rate

LONDON -- A single pill once a day for 8 weeks is enough to cure more than 90% of hepatitis C virus patients with relatively uncomplicated disease, a researcher said.

<乌鸦传媒>Treating HCV -- Is the Price Right?

New drugs on the horizon hold out the promise of being able to cure up to 90% of people with chronic hepatitis C (HCV). They are also promising to be expensive.

<乌鸦传媒>Studies 'Validate' CDC HCV Testing Advice

WASINGTON -- Thousands of people in the U.S. -- including an estimated 50,000 veterans -- are infected with the hepatitis C virus, and don't know it, researchers reported here.

<乌鸦传媒>Babies Do OK if Mom on Tenofovir for Hepatitis B

WASHINGTON -- Pregnant women being treated for hepatitis B virus infections with the nucleotide inhibitor tenofovir (Viread) appeared to avoid transmission of the pathogen to their unborn children, researchers reported here.

<乌鸦传媒>Interferon-Free Hepatitis C Tx Hits Snag

SEATTLE -- Results in a hard-to-treat patient population have clouded the future of a closely watched agent that acts against hepatitis C directly.

<乌鸦传媒>FDA Adds More Warnings for Lipitor, Crestor, and Zocor

WASHINGTON -- Statins may cause drug-drug interactions for patients taking drugs to treat HIV/AIDS or hepatitis C, according to a new statin warning from the FDA.

<乌鸦传媒>Herbal Supplement Suspect in Hepatitis

An herbal supplement containing artemisinin may have triggered hepatitis in a Seattle man who was given the supplement by a naturopathic provider for treatment of a parasitic infection.

<乌鸦传媒>High Normal ALT Limit Lowered for Male Adolescents

SYDNEY, Australia -- The upper limit of normal for the ALT liver enzyme in adolescent males has been too high, said researchers here.

<乌鸦传媒>Colonoscopy Patients Put at Infection Risk

MONROEVILLE, Pa.-About 200 patients who underwent colonoscopy at a Pittsburgh-area hospital were urged to undergo hepatitis and HIV testing because the colonoscopes were improperly disinfected.

3